Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vericiguat for prevention of ischemia-reperfusion injury in emergency PCI for acute myocardial infarction
ChiCTR2400089634Phase 4Not yet recruiting
- Sponsor
- Seventh People's Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of vericiguat in myocardial infarction (MI) (2 arms), sponsored by Seventh People's Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Primary endpoint: Major Adverse Cardiovascular Events (MACE). Planned start Sep 2024; status: not yet recruiting.
02
Drugs
vericiguat
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR2400089634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089634.